Ylva Naeser
PhD student at Department of Immunology, Genetics and Pathology; Research programme: Cancer Immunotherapy; Research group Gustav Ullenhag
- E-mail:
- ylva.naeser@igp.uu.se
- Visiting address:
- Akademiska sjukhuset, ingång 100/101
751 85 Uppsala - Postal address:
- Akademiska sjukhuset, ingång 100/101
751 85 Uppsala
Publications
Recent publications
-
Part of The Lancet Oncology, p. 1501-1510, 2025
-
The role of imaging in follow-up and prognosis of patients radically operated for melanoma
2024
-
Part of eClinicalMedicine, 2023
- DOI for Survival in patients diagnosed with melanoma in situ compared to the general population. A Swedish population-based matched cohort study
- Download full text (pdf) of Survival in patients diagnosed with melanoma in situ compared to the general population. A Swedish population-based matched cohort study
-
Part of Cancers, 2022
- DOI for Quality of Life in the First Year of Follow-Up in a Randomized Multicenter Trial Assessing the Role of Imaging after Radical Surgery of Stage IIB-C and III Cutaneous Melanoma (TRIM Study)
- Download full text (pdf) of Quality of Life in the First Year of Follow-Up in a Randomized Multicenter Trial Assessing the Role of Imaging after Radical Surgery of Stage IIB-C and III Cutaneous Melanoma (TRIM Study)
-
Part of Clinical Oncology: Case Reports, 2021
All publications
Articles in journal
-
Part of The Lancet Oncology, p. 1501-1510, 2025
-
Part of eClinicalMedicine, 2023
- DOI for Survival in patients diagnosed with melanoma in situ compared to the general population. A Swedish population-based matched cohort study
- Download full text (pdf) of Survival in patients diagnosed with melanoma in situ compared to the general population. A Swedish population-based matched cohort study
-
Part of Cancers, 2022
- DOI for Quality of Life in the First Year of Follow-Up in a Randomized Multicenter Trial Assessing the Role of Imaging after Radical Surgery of Stage IIB-C and III Cutaneous Melanoma (TRIM Study)
- Download full text (pdf) of Quality of Life in the First Year of Follow-Up in a Randomized Multicenter Trial Assessing the Role of Imaging after Radical Surgery of Stage IIB-C and III Cutaneous Melanoma (TRIM Study)
-
Part of Clinical Oncology: Case Reports, 2021
-
Part of BMC Cancer, 2020
- DOI for TRIM study protocol - a prospective randomized multicenter Trial to assess the Role of Imaging during follow-up after radical surgery of stage IIB-C and III cutaneous malignant Melanoma
- Download full text (pdf) of TRIM study protocol - a prospective randomized multicenter Trial to assess the Role of Imaging during follow-up after radical surgery of stage IIB-C and III cutaneous malignant Melanoma
-
Ghrelin is a prognostic marker and a potential therapeutic target in breast cancer
Part of PLOS ONE, 2017
- DOI for Ghrelin is a prognostic marker and a potential therapeutic target in breast cancer
- Download full text (pdf) of Ghrelin is a prognostic marker and a potential therapeutic target in breast cancer